Myomo, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 09, 2021 at 04:05 pm EDT
Share
Myomo, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 3.104 million compared to USD 858,590 a year ago. Operating loss was USD 2.599 million compared to USD 2.848 million a year ago. Net loss was USD 2.621 million compared to USD 3.286 million a year ago. Basic loss per share from continuing operations was USD 0.46 compared to USD 1.12 a year ago. For the half year, sales was USD 5.440 million compared to USD 1.866 million a year ago. Operating loss was USD 5.532 million compared to USD 6.270 million a year ago. Net loss was USD 5.582 million compared to USD 7.088 million a year ago. Basic loss per share from continuing operations was USD 1.03 compared to USD 3.27 a year ago.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patientâs own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individualâs ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteranâs administration, and others.
MYOMO, INC. 
